The percentage of patients 18-75 years of age with a serious mental illness and diabetes (type 1 and type 2) who received a nephropathy screening test or had evidence of nephropathy during the measurement year.
Note: This measure is adapted from an existing health plan measure used in a variety of reporting programs for the general population (NQF #0062: Comprehensive Diabetes Care: Medical Attention for Nephropathy). It is endorsed by NQF and is stewarded by NCQA.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Patients who received a nephropathy screening or monitoring test or had evidence of nephropathy during the measurement year.
-
1.15 Denominator
All patients 18-75 years as of December 31st of the measurement year with at least one acute inpatient visit or two outpatient visits for schizophrenia or bipolar I disorder, or at least one inpatient visit for major depression during the measurement year AND diagnosis of diabetes (type 1 and type 2) during the measurement year or the year before.
-
Exclusions
Patients who do not have a diagnosis of diabetes and who had a diagnosis of gestational or steroid-induced diabetes.
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Behavioral Health and Substance Use Fall Cycle 2019Initial EndorsementLast UpdatedRemoval Date
-
Steward Organization EmailSteward Organization Copyright
©2014 by the National Committee for Quality Assurance
1100 13th Street, NW, Suite 1000
Washington, DC 20005
-
-
-
Risk Adjustment
-